Partial Neuromuscular Blockade in Acute Respiratory Distress Syndrome
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
PNEUMA is a preliminary safety and feasibility trial of a novel approach to the titration of
neuromuscular blockade (NMB) to safe spontaneous breathing in patients with severe acute
respiratory distress syndrome (ARDS) supported with veno-venous extracorporeal membrane
oxygenation (VV-ECMO).